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对 PPARɑ和 Smad等相关分子调控的角度，探讨 OEA对脑缺血慢性期损伤改善
作用的机制。方法：应用大脑中动脉栓(middle cerebral artery occlusion, MCAO)
在 PPARɑ功能缺失小鼠和野生对照小鼠上建立脑缺血损伤模型，综合应用多种
行为学的评价方法观察 PPARɑ功能缺失对脑缺血后运动功能恢复的作用，并观
察 PPARɑ功能缺失对脑组织内胶质疤痕标志物 GFAP和 Neurocan表达的影响。
观察 PPARɑ激动剂 OEA对MCAO术后小鼠运动功能、胶质疤痕形成及轴突再





































Background: Cerebral ischemic stroke is a disease of the highest morbidity in the
world. Patients are always accompanied with chronic cerebral ischemia injury such as
long-term motor dysfunction. And it brings huge pain and heavy burden to patients
and their families. Currently, there are still no effective drugs for the treatment of
chronic cerebral ischemia injury. Therefore, it is of great significant to explore
effective drugs for the improvement of chronic brain injury after cerebral ischemia.
Studies found that the extracellular matrix synthesized and released by excessive
activated astrocytes in the the surrounding brain tissue near infarct, such as Neurocan,
can inhibite axonal regeneration and impede the recovery of neurological function.
Peroxisome proliferator-activated receptor alpha (PPARα) belonging to the
superfamily of nuclear receptor, is one kind of nuclear transcription factors activated
by ligands. We have reported that oleoylethanolamide (OEA), an agonist of PPARα,
exerts protective effect on the acute cerebral ischemia injury. However, whether OEA
promotes the recovery of motor function in the chronic phrase after stroke remains
unknown. Objective: To investigate the effect of OEA on the recovery of motor
function in the ischemic chronic phase, the effect of OEA on the formation of glial
scar and the effect of OEA on the regulations of PPARɑ and Smad2/3. Methods:
Cerebral ischemia was induced by middle cerebral artery occlusion (MCAO) in the
PPAR ɑ null mice and wild mice. The effect of PPARɑ dysfunction on the recovery of
motor function after cerebral ischemia was assessed by various behavioral tests in
PPAR ɑ null mice. The effect of PPARɑ dysfunction on the expressions of two glial
scar markers ( GFAP and Neurocan) in the brain tissue was also observed. The effects
of OEA, an agonist of PPARɑ, on the recovery of neurological function, glial scar
formation and the expressions of proteins related to axon regeneration (GAP43 and
SYN) afte brain ischemia were observed in an animal model of brain ischemia
induced by MCAO. Finally, the effects of OEA on the expressions of PPARɑ and
Smad in brain tissue after brain ischemia were evaluated to clarify the molecular
mechanism under the inhibiton effect of OEA on astrocytes scar formation.
Results: ：The disfunction of PPARɑ delayed the recovery of neurological function















OEA (10 mg/kg, ig) administrated after brain ischemia promoted the recovery of
motor function after MCAO in mice. OEA alleviated the over-activiation of astrocytes,
inhibited the formation of glial scar, upregulated the expressions of GAP43 and SYN.
OEA upregulated the expression of PPARɑ, downregulate the expression of Smad2/3
and PSmad2/3 in the brain tissue after brain ischemia. Conclusion: OEA can inhibit
the formation of glial scar, promote the axonal regeneration and improve the motor
function after MCAO. This protective role of OEA may be related to its regulating
effects on the expressions of PPAR ɑ and Smad2/3.
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